Cargando…
Invasive Fungal Infection Complicating Treatment With Ibrutinib
Ibrutinib is a selective Bruton’s tyrosine kinase inhibitor (BTKi) approved for the treatment of chronic lymphocytic leukemia (CLL) and other B-cell malignancies. Invasive fungal infections (IFIs) have recently been reported in patients on BTKis despite the absence of significant immunocompromise ra...
Autores principales: | Rajapakse, Pramuditha, Gupta, Manish, Hall, Rewaida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319755/ https://www.ncbi.nlm.nih.gov/pubmed/34336499 http://dx.doi.org/10.7759/cureus.16009 |
Ejemplares similares
-
Fungal Infection Post Arthroscopic Meniscal Repair: A Rare Complication
por: MLV, Sai Krishna, et al.
Publicado: (2023) -
A Rare Instance of Simultaneous Infection with Disseminated Nocardia and Pulmonary Aspergillus in a Patient Receiving Treatment with Ibrutinib for Chronic Lymphocytic Leukemia
por: Dotson, Jennifer, et al.
Publicado: (2018) -
Fatal Cryptococcal Meningitis in a Patient With Chronic Lymphocytic Leukemia Treated With Ibrutinib
por: Oumayma, Hari, et al.
Publicado: (2023) -
Challenges in the Management of Invasive Fungal Infections in the Middle East: Expert Opinion to Optimize Management Using a Multidisciplinary Approach
por: AlMaghrabi, Reem S, et al.
Publicado: (2023) -
Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
por: Grau, Santiago, et al.
Publicado: (2015)